Imperial College London

ProfessorJaneDavies

Faculty of MedicineNational Heart & Lung Institute

Professor of Paediatric Respirology & Experimental Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 7973j.c.davies

 
 
//

Assistant

 

Mrs Gina Rivellini +44 (0)20 7594 7986

 
//

Location

 

171Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Awards

  • Lead Principal Investigator and Outstanding Research Team Awards, NIHR NW London CRN, 2019
  • NIHR Lead Investigator Award Commercial Trials, NIHR, 2016
  • Imperial College President & Rector’s Award for Research Supervision 2013, Imperial College London, 2013
  • Imperial College President & Rector’s Gold Medal 2012, Imperial College London, 2012
  • Best Therapeutic Innovation (Respiratory) 2011, Medical Futures Innovation Award, 2011
  • MRC Translational Research Award 2011, Medical Futures Innovation Award, 2011
  • Imperial College Outstanding Research Team 2015, Imperial College London

External Positions

  • Member, Trial steering committee: Using medical-detection dogs to identify people with SARS-CoV-2. Phase I. Proof-of-concept studies, 2020
  • Deputy president, European CF Society, European CF Society, 2020
  • President, ECFS Global Conference, European CF Society, 2019
  • Chair, R-TRC CF National Strategic Research Group, NIHR, 2019
  • member/ Imperial representative, Steering Committee, NIHR, 2019
  • Clinical Professor of Paediatrics with special focus on Childhood Asthma, Invited external expert, Professorial appointment committee, University of Copenhagen, 2018
  • Chair, Clinical Trials Accelerator Platform (CTAP) Research & Scientific Oversight Committee, Cystic Fibrosis Trust, 2018
  • Member, European CF Society Board, European CF Society, 2018
  • Fellow, European Respiratory Society, European Respiratory Society, 2018
  • Lead, UK Clinical Trials Accelerator Platform London Network, Cystic Fibrosis Trust, 2018
  • Professor of Clinical Microbiology, Invited external expert, Professorial appointment committee, University of Copenhagen, 2017
  • Member, Respiratory Research Committee, Royal Brompton Hospital, 2017
  • Chair, Data Safety Monitoring Committee: HTA-funded ProteKt trial, HTA-funded ProteKt trial, 2016 - 2018
  • Member, ECFS Annual Global Conference: Organising Board, European CF Society, 2016 - 2019
  • Member, Clinical Research Oversight Committee, Royal Brompton Hospital, 2015
  • Member, Paediatric Lung Conditions Research Advisory Board, British Lung Foundation, 2015
  • Member, ECFS Annual Global Conference: Scientific Committee, European CF Society, 2014 - 2014
  • Chair, Research Committee, British Paediatric Respiratory Society, 2014
  • Paediatric Lead, Science & Research Committee, British Thoracic Society, 2014
  • Paediatric Lead, Training & Education Committee, British Thoracic Society, 2014 - 2019
  • Vice-chair, Strategic Advisory Board, Cystic Fibrosis Trust, 2013
  • Member, ECFS Annual Global Conference: Scientific Committee, European CF Society, 2012 - 2015
  • Member, NIHR Clinical Research Network, Paediatric Respiratory and Cystic Fibrosis Clinical Studies Group, NIHR, 2010
  • Member, Research Ethics Committee, Royal Brompton Hospital, 2007 - 2010
  • Member and Clinical Lead, Strategy Group UK CF Gene Therapy Consortium, Royal Brompton Hospital, 2000
  • Vice-chair, CF Trust Strategy Implementation grant review Board, Cystic Fibrosis Trust
  • Member, Diagnostic Working Group, European CF Society
  • Director, European Lung Clearance Index Core Facility, European CF Society
  • Vice-chair, Grant Review Board: CF Trust Strategy Implementation Board, Cystic Fibrosis Trust
  • Member, Grant Review Board: Gilead Sciences Research Scholars Program in Cystic Fibrosis, Gilead Sciences
  • Member, Grant Review Board: Vertex Innovations Awards, Vertex Pharmaceuticals
  • Member, Paediatric & CF working groups, European Respiratory Society
  • Member, Research Consultation Committee, Royal College of Paediatrics & Child Health
  • Respiratory Translational Research Collaborative (TRC), NIHR
  • Fellow, Royal College of Paediatrics & Child Health, Royal College of Paediatrics & Child Health
  • Principal Investigator, Site Lead Clinical Trials Network, European CF Society
  • Member, Standardisation Committee for Outcome measures, European CF Society
  • Lead, Strategic Task Force to speed access to new therapies, European CF Society

Industrial Connections

  • Algipharma, Clinical advisor in new treatments for CF
  • Boehringer Ingelheim, Clinical advisor in new treatments for CF
  • Chiesi, Clinical advisor in new treatments for CF
  • Eloxx, Clinical advisor in new treatments for CF
  • Enterprise Therapeutics, Clinical advisor in new treatments for CF
  • Ionis, Clinical advisor in new treatments for CF
  • Novartis, Clinical advisor in new treatments for CF
  • PTC Therapeutics, Clinical advisor in new treatments for CF
  • ProQR, Clinical advisor in new treatments for CF
  • Proteostasis, Clinical advisor in new treatments for CF
  • Pulmocide, Clinical advisor in new treatments for CF
  • Vertex Pharmaceuticals, Clinical advisor in new treatments for CF

Editorial Boards

  • Journal of Cystic Fibrosis, Deputy Editor, 2020
  • Thorax, Associate editor, 2014 - 2020
  • Pediatric Allergy, Immunology and Pulmonology, Editorial Board, 2010 - 2013
  • Paediatric Respiratory Reviews, Series Editor: New Biology of the Airways, 2002